Wockhardt (WOCKPHARMA) Share Price Falls 2.41% Today: Key Stock News
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Wockhardt Share Price fell today as the stock closed at Rs 1,928.10, below the previous close of Rs 1,975.70. That is a decline of Rs 47.60, or 2.41%, in a session where the company’s market capitalisation stood at Rs 32,103.58 Cr. Wockhardt is classified as a Large Cap company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data confirms the move, but it does not provide a company-specific trigger, so this article sticks to the verified price action, valuation context and peer data. For readers following Wockhardt Stock News, the key point is that the stock is down on the day and the available figures should be read as market data, not speculation.
The stock opened at Rs 1,979.85, matched that level as the day’s high, and later touched a low of Rs 1,925.00 before closing at Rs 1,928.10. Turnover for the session was Rs 0.58 Cr. That intraday pattern shows the price stayed near the upper end early in the session before declining toward the close. For anyone scanning Wockhardt Share Price Today, the movement is straightforward: the stock was down on the day, traded within the supplied range, and ended closer to the low than the open.
Wockhardt (WOCKPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,928.1 |
| Previous Close | Rs 1,975.7 |
| Today's Move | -Rs 47.60 (-2.41%) |
| Open | Rs 1,979.85 |
| High | Rs 1,979.85 |
| Low | Rs 1,925 |
| Turnover | Rs 0.58 crore |
| Market Capitalisation | Rs 32,103.58 crore |
| Market Cap Category | Large Cap |
Wockhardt Share Price Today shows a verified one-day decline from Rs 1,975.70 to Rs 1,928.10. The stock moved Rs 47.60 lower after opening at Rs 1,979.85 and printing a high at the same level before slipping to Rs 1,925.00. The close was only slightly above the low, which indicates that selling pressure dominated the later part of the session. The turnover figure of Rs 0.58 Cr is exactly as supplied. Wockhardt Share Price readers should note that the data confirms the fall, but it does not identify a separate news event or operational reason behind it.
Wockhardt (WOCKPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 32,103.58 crore |
| P/E Ratio | 78.49x |
| P/B Ratio | 6.38x |
| ROE | 4.29% |
| ROCE | 6.79% |
| EPS | Rs 25.17 |
| Book Value Per Share | Rs 309.81 |
| Dividend Yield | 0% |
Wockhardt Share Price also needs to be read with the company’s valuation and profitability profile. The stock trades at a P/E of 78.49 and a P/B of 6.38. EPS is Rs 25.17, while book value per share is Rs 309.81. ROE is 4.29% and ROCE is 6.79%, and dividend yield is 0. These are the exact figures supplied in the dataset. In simple terms, the market is assigning a relatively high multiple to the stock while the reported return ratios remain modest. That does not explain today’s decline by itself, but it does frame why Wockhardt Fundamental Analysis often centers on whether the current share price already reflects stronger future performance than the present ratios indicate.
At the company-size level, Wockhardt’s market capitalisation of Rs 32,103.58 Cr places it in the Large Cap bracket. Market cap reflects size rather than quality, so the more useful check is how the earnings base and return ratios compare with the valuation. EPS of Rs 25.17 and book value of Rs 309.81 provide the basic per-share accounting context, while ROE and ROCE show how efficiently capital is being used. For Wockhardt Share Price Update readers, the important observation is that valuation is high relative to both the company’s book value and the industry’s median multiples, while profitability remains below several benchmark levels.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 78.49x |
| Benchmark Median P/E | 31.21x |
| Benchmark Average P/E | 48.1x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 6.38x |
| Benchmark Median P/B | 2.88x |
| Benchmark Average P/B | 4.19x |
| Company ROE | 4.29% |
| Benchmark Median ROE | 11.78% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 6.79% |
| Benchmark Median ROCE | 13.6% |
| Benchmark Average ROCE | 13.27% |
| Company Market Capitalisation | Rs 32,103.58 crore |
| Benchmark Median Market Cap | Rs 670.73 crore |
| Benchmark Average Market Cap | Rs 14,040.53 crore |
Wockhardt operates in the Healthcare sector and the Pharmaceuticals & Drugs industry, with the benchmark scope covering 203 companies in the same industry. Against that set, Wockhardt’s P/E of 78.49 is above the median 31.21 and above the average 48.1. Its P/B of 6.38 is also above the median 2.88 and above the average 4.19. On the profitability side, ROE of 4.29% is below the median 11.78% and average 10.68%, while ROCE of 6.79% is below the median 13.6% and average 13.27%. This is the core sector reading for Wockhardt Share Price: the valuation is elevated relative to the industry, while return ratios remain below the benchmark centre.
Market capitalisation adds another layer. The industry median market cap is Rs 670.73 Cr and the average is Rs 14,040.53 Cr, while Wockhardt is at Rs 32,103.58 Cr. That places the company well above both reference points. For Wockhardt Share Price Today readers, the takeaway is not a forecast; it is a comparison. The stock sits in a large listed company bracket, trades above sector medians on valuation, and shows weaker-than-benchmark return ratios. Univest uses that mix of numbers to keep Wockhardt Stock News grounded in data.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,60,696.31 | 38.09 | 5.33 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,062.83 | 84.12 | 13.93 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,91,515.22 | 87.81 | 21.34 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,18,403.7 | 26.24 | 4.39 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
Wockhardt Share Price can be read more clearly against peers in the same healthcare and pharmaceuticals & drugs space. Sun Pharmaceutical Industries has a much larger market cap at Rs 460,696.31 Cr, with a lower P/E of 38.09 and P/B of 5.33, though higher ROE and ROCE than Wockhardt. Divi’s Laboratories trades at a P/E of 84.12 and P/B of 13.93, with stronger return ratios. Torrent Pharmaceuticals shows even higher valuation multiples and higher ROE. Zydus Lifesciences carries a lower P/E of 26.24 and P/B of 4.39, with stronger returns than Wockhardt. Cipla also trades at lower valuation multiples and higher profitability ratios. In that peer frame, Wockhardt Stock Analysis looks expensive relative to several comparables while return ratios remain softer.
Why Investors Are Watching Wockhardt
- Wockhardt Share Price fell 2.41% today to Rs 1,928.10 after closing below the previous close of Rs 1,975.70.
- The stock opened and hit a day high of Rs 1,979.85 before touching a day low of Rs 1,925.00.
- Market capitalisation is Rs 32,103.58 Cr, and the company is classified as Large Cap.
- P/E is 78.49 and P/B is 6.38, while ROE is 4.29% and ROCE is 6.79%.
- Compared with the same-industry benchmark, valuation sits above the median while return ratios sit below the median.
About Wockhardt
Wockhardt belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies it as a Large Cap company with a market capitalisation of Rs 32,103.58 Cr. For readers checking Wockhardt Stock News, that is the confirmed company profile available in this dataset. Univest keeps Wockhardt Share Price coverage tied to verified market and classification information rather than unsupported business assumptions.
Track Wockhardt Share Price on Univest
Use Wockhardt (WOCKPHARMA) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
Investors can track Wockhardt Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels and market insights. The platform also helps users follow Wockhardt Share Price Today, Wockhardt Stock News and Wockhardt Share Price Update in one place, with a clean view of market context and company data.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Wockhardt Share Price today?
Ans. Wockhardt Share Price today is Rs 1,928.10. The stock closed below the previous close of Rs 1,975.70 after moving between Rs 1,925.00 and Rs 1,979.85 during the session. The previous close was Rs 1,975.7.
What is Wockhardt’s market capitalisation?
Ans. Wockhardt’s market capitalisation is Rs 32,103.58 Cr. The company is classified as Large Cap, which provides company-size context for Wockhardt Share Price Today and its market-news coverage. The company operates in the Healthcare sector.
How do Wockhardt’s valuation metrics look?
Ans. Wockhardt trades at a P/E of 78.49 and a P/B of 6.38. EPS is Rs 25.17 and book value is Rs 309.81, giving context for Wockhardt Fundamental Analysis. The company trades at a P/E ratio of 78.49x.
How does Wockhardt compare with sector benchmarks?
Ans. In the same-industry benchmark of 203 companies, Wockhardt’s P/E of 78.49 is above the median 31.21, while ROE of 4.29% and ROCE of 6.79% are below the benchmark medians. The stock belongs to the Healthcare sector.
How does Wockhardt compare with listed peers?
Ans. Compared with peers such as Sun Pharma, Cipla and Zydus Lifesciences, Wockhardt has a higher P/E than some names and lower profitability ratios than several peers, based on the supplied figures.
What should investors monitor next in Wockhardt Share Price?
Ans. Investors can monitor the next session’s price path, the company’s valuation versus the healthcare benchmark, and any new company news. Univest tracks these updates alongside Wockhardt Share Price Today. The previous close was Rs 1,975.7.
